Behind the rise of Nigeria’s most valuable pharmaceutical companies is a group of chief executives turning economic challenges into growth, lifting their firms’ market value and strengthening investor confidence.
The healthcare sector comprises several subsectors, including healthcare manufacturing, pharmaceuticals, hospitals, and laboratories.
Data from the National Bureau of Statistics (NBS) shows that Nigeria’s healthcare sector, classified under Human Health and Social Services, grew by 1.99 percent in the first quarter of 2026, compared to 1.76 percent for the corresponding period of 2025, which shows an increase of 0.24 percent.
The growth in Q1 2026 was lower than the growth recorded in Q4 2025 by 0.76 percent.
Notably, the healthcare sector has achieved GDP growth in every quarter since 2020. In nominal terms, the healthcare sector’s GDP stands at N1.47 trillion, contributing approximately 0.013 percent to the overall GDP.
The nominal GDP of the healthcare sector closely aligns with the combined
This post was originally published on this site.
